Difference between psychostimulant users and opioid users in recovery of cognitive impairment, measured with the Montreal Cognitive Assessment (MoCA®)
- 19 August 2021
- journal article
- research article
- Published by Taylor & Francis in Journal of Substance Use
- Vol. 27 (6) , 611-615
Abstract
Substance use disorder (SUD) can lead to cognitive impairment. The objective of our study is to investigate differences in cognitive impairment between psychostimulant users and opioid users after ...Keywords
This publication has 25 references indexed in Scilit:
- Prevalence of attention-deficit hyperactivity disorder in substance use disorder patients: A meta-analysis and meta-regression analysisDrug and Alcohol Dependence, 2012
- Effects of Cognitive Impairment on Substance Abuse Treatment Attendance: Predictive Validation of a Brief Cognitive Screening MeasureThe American Journal of Drug and Alcohol Abuse, 2012
- Psychosocial interventions for retention in drug abuse treatment2010
- Rapid cognitive screening of patients with substance use disorders.Experimental and Clinical Psychopharmacology, 2009
- Cognitive functioning in substance abuse and dependence: a population‐based study of young adultsAddiction, 2009
- The Neuropsychology of Amphetamine and Opiate Dependence: Implications for TreatmentNeuropsychology Review, 2007
- Profile of Executive and Memory Function Associated with Amphetamine and Opiate DependenceNeuropsychopharmacology, 2005
- The Montreal Cognitive Assessment, MoCA: A Brief Screening Tool For Mild Cognitive ImpairmentJournal of the American Geriatrics Society, 2005
- Neuropsychological Characteristics of Adults with ADHD: A Comprehensive Review of Initial StudiesThe Clinical Neuropsychologist, 2002
- Ability of counselors to detect cognitive impairment among substance-abusing patients: An examination of diagnostic efficiency.Experimental and Clinical Psychopharmacology, 1997